APPLICATION
ANDA207547
TYPE
ANDA
ORIGINAL APPROVAL
2017-02-13
LATEST ACTION
2022-12-14
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Discontinued
Products
LEVOLEUCOVORIN CALCIUMDiscontinued
LEVOLEUCOVORIN CALCIUM EQ 50MG BASE/VIAL · POWDER · INTRAVENOUS
Approval history
2022-12-14Labeling · Supplement 1 · standardAP
2022-12-14Labeling · Supplement 7 · standardAP
2017-02-13UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.